Showing results (101-110 of 432) with videos related to
Sort By:
Pageof 44
Neoplasia (New York, N.Y.)|September 13, 2013
AR variant ARv567es induces carcinogenesis in a novel transgenic mouse model of prostate cancerGang Liu, Cynthia Sprenger, Shihua Sun, et al.Medical Oncology (Northwood, London, England)|June 15, 2016
Docetaxel-related toxicity in metastatic hormone-sensitive and metastatic castration-resistant prostate cancerMichael T Schweizer, Roman Gulati, Elahe A Mostaghel, et al.The Prostate|April 25, 2003
LuCaP 35: a new model of prostate cancer progression to androgen independenceEva Corey, Janna E Quinn, Kent R Buhler, et al.Journal of Proteome Research|April 13, 2012
Integrative analysis of N-linked human glycoproteomic data sets reveals PTPRF ectodomain as a novel plasma biomarker candidate for prostate cancerTheodore E Whitmore, Amelia Peterson, Ted Holzman, et al.Proceedings of the National Academy of Sciences of the United States of America|October 1, 2021
Computational modeling identifies multitargeted kinase inhibitors as effective therapies for metastatic, castration-resistant prostate cancerThomas Bello, Claudia Paindelli, Luis A Diaz-Gomez, et al.Cancer Research|January 20, 2004
Quantitative proteomic analysis of proteins released by neoplastic prostate epitheliumDaniel B Martin, David R Gifford, Michael E Wright, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 23, 2014
Rapid induction of androgen receptor splice variants by androgen deprivation in prostate cancerZiyang Yu, Sen Chen, Adam G Sowalsky, et al.Chemico-Biological Interactions|December 17, 2014
The DHEA-sulfate depot following P450c17 inhibition supports the case for AKR1C3 inhibition in high risk localized and advanced castration resistant prostate cancerDaniel Tamae, Elahe Mostaghel, Bruce Montgomery, et al.American Journal of Clinical and Experimental Urology|November 9, 2023
Determining clinical perspectives and strategies for improving enrollment of minoritized communities in prostate cancer clinical trialsLauren Brady, Jenney R Lee, Evan Y Yu, et al.The Prostate|February 19, 2010
Differential expression of the alpha2 chain of the interleukin-13 receptor in metastatic human prostate cancer ARCaPM cellsHui He, Jianchun Xu, Peter S Nelson, et al.Pageof 44